The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists

Gastroenterology. 2021 Apr;160(5):1885-1886. doi: 10.1053/j.gastro.2020.06.087. Epub 2020 Jul 6.

Authors

Maria Cappello¹, Anita Busacca¹, Laura Guida¹

Affiliation

¹ Gastroenterology & Hepatology Section, Promise, University of Palermo, Palermo, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenal Cortex Hormones
COVID-19*
Humans
Inflammatory Bowel Diseases* / drug therapy
Registries
SARS-CoV-2
Tumor Necrosis Factor Inhibitors

Substances

Adrenal Cortex Hormones
Tumor Necrosis Factor Inhibitors